Armata Pharmaceuticals, Inc. (ARMP)
ASE · Healthcare · Biotechnology
$7.58
+1.47%
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
Market Cap
$278.3M
Shares Outstanding
36.7M
Exchange
ASE
Currency
USD
About Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA03 for Pseudomonas aeruginosa . The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. is a subsidiary of Innoviva, Inc.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -6.8M | -7.8M | -8.4M | -8.8M |
| Net Income | -16.3M | -26.7M | -124.3M | -115.3M |
| Diluted EPS | $-0.45 | $-0.74 | $nan | $-3.16 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -36.9M | -40.9M | -42.4M | -31.2M |
| Net Income | -36.9M | -69.0M | -18.9M | -173.8M |
| Diluted EPS | $-1.08 | $-1.91 | $-0.89 | $-4.80 |